Conclusion: This is a first report associating DNA methylation signature with abstinence in alcoholics treated with acamprosate. Future studies are needed to investigate the value of this association as a potential biomarker of acamprosate response in treatment-seeking alcoholics.
memantine would improve cognitive function of patient with alcoholic dementia. The aim of this study was to testify this hypothesis and to evaluate its effect of cognitive improvement of patient with alcoholic dementia. Method: The study is planned as a 12-week, open-label study of 20mg memantine, a NMDA antagonist, as treatment for cognitive and neurobiological problem in patients with alcoholic dementia. CERAD-K and K-MMSE was administered to total 27 male patients diagnosed as alcoholic dementia according to the DSM-IV criteria before and after 12-week memantine medication. Results: Word list recall, word list recognition, time orientation, drawing a interlocking pentagon, and K-MMSE total score of the patients were improved significantly after the memantine trial. Conclusions: Memantine has significant effects on the cognitive function improvement of the patients with alcoholic dementia. Limitation and future direction of this study were discussed.
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Case study on alcohol withdrawal with transient periodic synchronous discharge Abstract There are few reported case studies on alcohol withdrawal syndrome with periodic synchronous discharge （PSD）. We report the case study of a middle-aged man diagnosed with alcohol withdrawal syndrome and transient PSD. The patient was an alcoholic who had been repeatedly hospitalized. During treatment on an outpatient basis, the patient suffered a convulsive attack and delirium related to alcohol withdrawal after drinking, and was hospitalized. His withdrawal symptoms improved after hospitalization. When he completed the alcoholism treatment program, a trial stay overnight at home was attempted. During the stay, the patient drank again. After returning to the hospital, he again suffered from alcohol withdrawal related delirium, indicated disturbance of consciousness and inconsistent behaviors. Electroencephalography was conducted, which indicated PSD. However, a head MRI did not show any abnormal findings. Since the disturbance of his consciousness was prolonged, valproic acid 1200mg was administered, which improved his disturbances in consciousness and the abnormal electroencephalogram. It is suggested that chronic exposure to alcohol might make the brain vulnerable and develop a kindling phenomenon, or a preparatory state for convulsions. It is also suggested that abnormal electroencephalograms might reflect the severity of alcohol dependence.
